4//SEC Filing
Robb Gary Charles 4
Accession 0000950170-25-081932
CIK 0001088856other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:32 PM ET
Size
11.3 KB
Accession
0000950170-25-081932
Insider Transaction Report
Form 4
Robb Gary Charles
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-06-03$71.68/sh−651$46,664→ 16,549 total - Award
Common Stock
2025-06-02$71.68/sh+997$71,465→ 16,203 total
Holdings
- 11,571(indirect: By Children)
Common Stock
Footnotes (8)
- [F1]The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 2, 2025.
- [F2]In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
- [F3]Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F4]Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
- [F5]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- [F6]The closing price on June 2, 2025 was used to calculate the withholding obligation.
- [F7]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- [F8]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001529655
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:32 PM ET
- Size
- 11.3 KB